Goldman Sachs’s Whitehawk Therapeutics, Inc. Common Stock WHWK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-154,270
Closed -$225K 5034
2024
Q2
$225K Buy
154,270
+104,691
+211% +$153K ﹤0.01% 4316
2024
Q1
$116K Buy
+49,579
New +$116K ﹤0.01% 4437
2023
Q3
Sell
-25,215
Closed -$172K 4980
2023
Q2
$172K Buy
25,215
+519
+2% +$3.55K ﹤0.01% 4442
2023
Q1
$179K Sell
24,696
-2,643
-10% -$19.1K ﹤0.01% 4556
2022
Q4
$351K Buy
27,339
+1,563
+6% +$20.1K ﹤0.01% 4271
2022
Q3
$364K Sell
25,776
-17,886
-41% -$253K ﹤0.01% 4439
2022
Q2
$538K Sell
43,662
-15,885
-27% -$196K ﹤0.01% 4331
2022
Q1
$1.01M Buy
+59,547
New +$1.01M ﹤0.01% 4089
2020
Q3
Sell
-1,960
Closed -$37K 4587
2020
Q2
$37K Buy
+1,960
New +$37K ﹤0.01% 4279
2020
Q1
Sell
-54,565
Closed -$510K 4580
2019
Q4
$510K Sell
54,565
-41,282
-43% -$386K ﹤0.01% 3642
2019
Q3
$977K Sell
95,847
-7,097
-7% -$72.3K ﹤0.01% 3263
2019
Q2
$1.41M Buy
+102,944
New +$1.41M ﹤0.01% 2997
2018
Q4
Sell
-7,230
Closed -$335K 4268
2018
Q3
$335K Buy
+7,230
New +$335K ﹤0.01% 3625